Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 12Tumor of Exocrine Pancreas 1Resectable Pancreatic Carcinoma 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Intraductal Neoplasms 1Neoplasm Metastasis 1Locally Advanced Pancreatic Cancer 1Kidney Failure, Chronic 1Gastroparesis 1Cholangiocarcinoma 1Carcinoma, Acinar Cell 1Adenoma, Islet Cell 1

Interventions

pembrolizumab 1paricalcitol 1X-Rays 1Taxes 1Specimen Handling 1Pancreatectomy 1Hemoglobins 1Gemcitabine 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Resectable Pancreatic Carcinoma × Pancreatectomy × Clear all
NCT05841706 2025-06-10

Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer

Jonsson Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
1 enrolled
Gastrointestinal

Resectable Pancreatic Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡